山西蚊子解剖模型河南额骨模型,西宁电脑高级全功能急救训练模拟人(心肺复苏CPR与血压测量等功能),胎儿妊娠发育过程模型（8部件）购买,江苏牙齿发育顺序模型,哈尔滨消化内镜诊疗模拟教学培训系统,甘肃脑脊髓与周围神经解剖模型(椎管内脊髓与脊神经),云南高级老年人褥疮（压疮）护理模型

The College Football Playoff picture is set.The top four teams in the playoff field are LSU, Ohio State, Clemson and Oklahoma, in that order, the selection committee announced Sunday.In the semifinals, LSU (13-0) will face Oklahoma (12-1) at the Chick-fil-A Peach Bowl at Mercedes-Benz Stadium in Atlanta, while Ohio State (13-0) will take on Clemson (13-0) at the PlayStation Fiesta Bowl at State Farm Stadium in Glendale, Arizona. Both of those games will be December 28.The national championship game is January 13 at the Mercedes-Benz Superdome in New Orleans.Before Sunday's reveal, the top four teams in the ranking had been Ohio State, LSU, Clemson and Georgia. Fifth through seventh were Utah, Oklahoma and Baylor, respectively.The landscape started shifting Friday night, when Utah lost to Oregon in the Pac-12 title game. Then on Saturday Oklahoma beat Baylor to win the Big 12 title. Later that day the Sooners got some 943

The NFL announced on Tuesday that the number of teams that will qualify for the playoffs will expand from 12 to 14, which will also increase the number of Wild Card Round games from four to six. NFL owners and the Players Association came to the agreement on Tuesday, which will go into effect this season. The format will mean that only the top team in each conference will earn a bye into the Divisional Round. The six division winners will then play the six wild card teams. The new format marks the first time the NFL has expanded the playoffs since 1990, when the league increased the number of teams that qualified from 10 to 12. Per the new format, three playoff games will be played on Saturday, Jan. 9, and another three games will be played on Sunday, Jan. 10. NBC and CBS have been the selected networks to air the added two showdowns. Had this year's format been in place in 2019, the Pittsburgh Steelers and Los Angeles Rams would have earned playoff bids. 982

Temperatures in Colorado plunged 64 degrees on Thursday, the largest temperature drop the state has ever seen in October.It's also the 15th largest temperature drop over a two day period in Denver's history, according to 232

The first day of school can be a scary experience for young children, but one boy in Wichita, Kansas, is very lucky to have a friend guide him.Connor Crites has autism and is nonverbal, 198

The FDA said on Tuesday it has developed guidelines to take plasma from coronavirus survivors to treat patients who are critically ill from the virus. The FDA said on Tuesday that It is possible that convalescent plasma contains antibodies to the coronavirus and might be effective against the infection. The FDA said that although the announcement is promising, convalescent plasma has not been shown to be effective in every disease studied. The FDA is not approving using plasma as a treatment, instead using it as a clinical trial and for the treatment of those who are critically ill. "Given the public health emergency that the expanding COVID-19 outbreak presents, while clinical trials are being conducted, FDA is facilitating access to COVID-19 convalescent plasma for use in patients with serious or immediately life-threatening COVID-19 infections," the FDA said. The plasma will be collected from recovered individuals only if they are eligible to donate blood. The FDA said on Sunday that it was altering its guidelines on Risk Evaluation and Mitigation Strategy (REMS)-required testing, which allows healthcare providers to weigh the benefits of an experimental drug over its risks.“The FDA recognizes that during the COVID-19 public health emergency, the completion of some REMS-required laboratory testing or imaging studies may be difficult because patients suspected of having COVID-19 may be self-isolating and/or subject to quarantine,” said FDA Principal Deputy Commissioner Amy Abernethy, M.D., Ph.D. “Under these circumstances, undergoing testing or imaging studies in order to obtain a drug that is subject to a REMS can put patients and others at risk for transmission of the coronavirus. We will continue to work with sponsors to ensure that patients have appropriate access to the medications they need.” 1843